Efficacy and Safety of Rituximab in Autoimmune Disease—Associated Interstitial Lung Disease: A Prospective Cohort Study

Objectives: To analyze the efficacy and safety of rituximab (RTX) in connective tissue disease associated with interstitial lung disease (CTD-ILD). Methods: We performed a multicenter, prospective, observational study of patients with CTD-ILD receiving rituximab between 2015 and 2020. The patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Mena-Vázquez, Natalia, Redondo-Rodríguez, Rocío, Rojas-Gimenez, Marta, Romero-Barco, Carmen María, Manrique-Arija, Sara, Ortega-Castro, Rafaela, Hidalgo Conde, Ana, Arnedo Díez de los Ríos, Rocío, Cabrera César, Eva, Espildora, Francisco, Aguilar-Hurtado, María Carmen, Añón-Oñate, Isabel, Pérez-Albaladejo, Lorena, Abarca-Costalago, Manuel, Ureña-Garnica, Inmaculada, Velloso-Feijoo, Maria Luisa, Irigoyen-Oyarzábal, Maria Victoria, Fernández-Nebro, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879100/
https://www.ncbi.nlm.nih.gov/pubmed/35207203
http://dx.doi.org/10.3390/jcm11040927

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879100/
https://www.ncbi.nlm.nih.gov/pubmed/35207203
http://dx.doi.org/10.3390/jcm11040927

Ejemplares similares